Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG Oncology/RTOG 0813 trial

Andrea Bezjak, Rebecca Paulus, Laurie E. Gaspar, Robert D. Timmerman, William L. Straube, William F. Ryan, Yolanda I. Garces, Anthony T. Pu, Anurag K. Singh, Gregory M. Videtic, Ronald C. McGarry, Puneeth Iyengar, Jason R. Pantarotto, James J. Urbanic, Alexander Y. Sun, Megan E. Daly, Inga S. Grills, Paul Sperduto, Daniel P. Normolle, Jeffrey D. BradleyHak Choy

Research output: Contribution to journal › Article › peer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG Oncology/RTOG 0813 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences